Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;21(1):86-91.
doi: 10.1038/nm.3743. Epub 2014 Dec 15.

In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire

Affiliations

In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire

Brandon J DeKosky et al. Nat Med. 2015 Jan.

Abstract

High-throughput immune repertoire sequencing has emerged as a critical step in the understanding of adaptive responses following infection or vaccination or in autoimmunity. However, determination of native antibody variable heavy-light pairs (VH-VL pairs) remains a major challenge, and no technologies exist to adequately interrogate the >1 × 10(6) B cells in typical specimens. We developed a low-cost, single-cell, emulsion-based technology for sequencing antibody VH-VL repertoires from >2 × 10(6) B cells per experiment with demonstrated pairing precision >97%. A simple flow-focusing apparatus was used to sequester single B cells into emulsion droplets containing lysis buffer and magnetic beads for mRNA capture; subsequent emulsion RT-PCR generated VH-VL amplicons for next-generation sequencing. Massive VH-VL repertoire analyses of three human donors provided new immunological insights including (i) the identity, frequency and pairing propensity of shared, or 'public', VL genes, (ii) the detection of allelic inclusion (an implicated autoimmune mechanism) in healthy individuals and (iii) the occurrence of antibodies with features, in terms of gene usage and CDR3 length, associated with broadly neutralizing antibodies to rapidly evolving viruses such as HIV-1 and influenza.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunogenetics. 2012 Jan;64(1):3-14 - PubMed
    1. Science. 2011 Aug 12;333(6044):850-6 - PubMed
    1. Analyst. 2012 Jul 7;137(13):2951-7 - PubMed
    1. J Control Release. 2001 May 18;73(1):59-74 - PubMed
    1. Front Immunol. 2014 Jan 23;5:12 - PubMed

Publication types

MeSH terms